Results 121 to 130 of about 32,499 (205)

Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]

BMC Infect Dis
O'Rourke J, Townsend CL, Milanzi E, Castro H, Collins IJ, Judd A, Jesson J, Leroy V, Penazzato M, Vicari M, Renaud F.   +10 more
europepmc   +1 more source

Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions. [PDF]

Front Pharmacol
Chen B, Li L, Xu W, Xu H, Zhu X, He Q, Zhu X, Chi-Lui Ho P, Xiang X, Ji P.   +9 more
europepmc   +1 more source

HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]

Case Rep Infect Dis
Tchiakpe E, Diop-Ndiaye H, Osawe S, Toure-Kane C, Yessoufou A.   +4 more
europepmc   +1 more source

Effects of Ritonavir, Lopinavir, and Alcohol on ABC Transporters and Secretion of Bile Acid and Bilirubin in Senescent Hepatocytes. [PDF]

Int J Mol Sci
Chen L, Duran E, Headrick D, Ji C.
europepmc   +1 more source

In Vitro Validation of Size-Dependent Antiviral Activity of <i>Phaeodactylum tricornutum</i>-Derived Peptide Fractions Against SARS-CoV-2. [PDF]

Mar Drugs
Cañedo-Figueroa DM, Márquez-Reyna BA, Santos-Mena AO, Calderón-Sandate DN, Lira-Hernández FI, Castañeda-Delgado JE, García-Herrera AC, Del Ángel RM, León-Juárez M, Valdez-Flores MA, López-Angulo G, Norzagaray-Valenzuela CD, Calderón-Zamora L, Cervantes-Bobadilla E, Osuna-Ramos JF, De Jesús-González LA.   +15 more
europepmc   +1 more source

Repurposing HIV Protease Inhibitors against West Nile Virus: Insights from Molecular Docking and Molecular Dynamics Simulations. [PDF]

ACS Phys Chem Au
Dos Santos RD, Colherinhas G, Cardoso WB.   +2 more
europepmc   +1 more source

Longitudinal Clinical and Molecular Characterization of a Single Pediatric Case of Vertically Acquired HIV-1 Subtype C with Baseline Resistance to Protease Inhibitors. [PDF]

Microorganisms
Zaher KA, El-Daly MM, Zaki EA, Alhazmi MM, Abdulhaq A, El-Kafrawy SA, Azhar EI.   +6 more
europepmc   +1 more source

Drying stability and permeability advantages of amorphous drug nanoparticles. [PDF]

AAPS Open
Narula A, Lale A, Chakravarty P, Li N.
europepmc   +1 more source

Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China. [PDF]

Prev Med Rep
Cheng W, Zhang Y, Yang J, Jiang J, Pan X, Chai C, Wang Y.   +6 more
europepmc   +1 more source

Mapping the intellectual landscape of malaria drug repurposing: a systematic analysis of the 51 most cited studies. [PDF]

Malar J
Tizhe DT, Ogra IO, Adaji JZ, Usman S, Apeji YE, Kwaga JKP, Kia GSN, Sossou K.   +7 more
europepmc   +1 more source